Skip to content
Bikanta logo

Bikanta

Bikanta is a YC Summer 2014 (S14) company. Based in Berkeley, CA, USA. Team of 2.

  • Nanomedicine

About Bikanta

GPAgent's own fund-neutral profile, written from public information. Updated Oct 5, 2026.

Summary

Bikanta develops nanodiamond-based imaging probes for medical diagnostics and research. The probes are fluorescent, stable, and non-toxic, enabling optical imaging with far greater signal clarity than conventional fluorescence techniques. Researchers and clinicians use them to detect diseases and investigate biological questions that standard imaging tools cannot resolve.

From the Y Combinator listing

How Bikanta describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

Nano-diamonds for cancer detection

Bikanta is introducing revolutionary nanodiamond-based technology to push the boundaries of current medical imaging and diagnostics, allowing researchers to answer questions and medics to detect diseases that they currently cannot. A nanodiamond is forever. They are brightly fluorescent, infinitely stable, non-toxic, functionalizable and can be used for background-free optical imaging. Early results have improved the signal by as much as 100-fold over conventional fluorescence imaging techniques. Bikanta’s vision is to redefine the boundaries of medical diagnostics by delivering cutting-edge imaging probes and background-free optical imaging.

Facts

Industry
Healthcare / Healthcare -> Diagnostics
Location
Berkeley, CA, USA
Team size
2
Status
Inactive
Stage
Early

Founders (1)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works